BRIEF-Ranbaxy to resume manufacture of generic Lipitor for U.S.
Feb 22 (Reuters) - Ranbaxy Laboratories Ltd : * Says resuming manufacture of generic lipitor for U.S.
- U.S. Mega Millions lottery up to $400 million, 2nd-biggest ever
- Uruguay becomes first country to legalize marijuana trade
- Pope Francis named Time's Person of the Year
- Thousands of South Africans line up to see Mandela lie in state |
- China bitcoin arbitrage ends as traders work around capital controls